cancer

Pancreatic cancer treatment pipeline dominated by early-stage development Research

Read more

Molecular tinkering doubles cancer drug’s efficacy

Read more

BI’s afatinib LUX-Lung 8 trial data released at ASCO 2015

Read more

Boehringer Ingelheim announces OS results from LUX-Lung 8 trial at ASCO 2015

Read more

Cancer Genetics in agreement with ReproCELL

Read more

Merck receives FDA Fast Track Designation for Evofosfamide

Read more

Scientists develop new drug to reverse resistance to immunotherapy

Read more